🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Content Removal

According to the social media company, the service has taken down problematic material and banned related hashtags and query recommendations. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of members, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.

Within minutes of entering one group, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.

Product Details and Pricing

Within these groups, messages display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant medical dangers”.